跳至主要内容
临床试验/CTRI/2023/08/056626
CTRI/2023/08/056626尚未招募2 期

To evaluate the role of intralesional bleomycin in cases of periocular capillary hemangioma unresponsive to oral propranolol

Rp center institute of ophthalmic sciences1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年8月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
10
试验地点
1
主要终点
Comparing the area of the lesion , maximum horizontal diameter , maximum vertical diameter , color change , percentage of area reduction

研究概览

简要总结

Prospective interventional study to evaluate the role of intralesional bleomycin in patients of periocular hemangiomas unresponsive to oral propranolol .since surgery , corticosteroids and radiation therapy has side effects.Currently there is paucity of prospective interventional studies regarding the same.Retrospective studies showed benefit of the intralesional bleomycin injections

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
0.00 Day(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • All periocular capillary hemangioma patients 0-18 years who are resistant to oral propranolol.

排除标准

  • Age > 18 years Capillary hemangioma responding to oral propranolol.

结局指标

主要结局

Comparing the area of the lesion , maximum horizontal diameter , maximum vertical diameter , color change , percentage of area reduction

时间窗: At baseline , 1 week , 4 weeks , 2 months , 3 months and 6 months

次要结局

  • Change in BCVA , percentage reduction in area(2 weeks , 1 month , 3 months , 6 months)

研究者

发起方
Rp center institute of ophthalmic sciences
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验